All In Biotech

Drug Trial Radar · NCT06901830

A Study of YZJ-4729 Tartrate Injection for the Treatment of Pain After Orthopedic Surgery

A PhaseⅡ, Randomized, Double-Blind, Placebo- and Active- Controlled Study of YZJ-4729 Tartrate Injection for the Treatment of Moderate to Severe Pain After Orthopedic Surgery

Last checked: Nov 20, 2026Latest source record: Jun 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 150 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

150

Actual

Start

May 23, 2025

Primary completion

Dec 6, 2025

Study completion Dec 18, 2025

Sponsor

Sponsor type
Industry
First posted
Mar 30, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective is to evaluate the analgesic efficacy and safety of IV YZJ-4729 Tartrate Injection in patients with acute postoperative pain following Orthopedic surgery

Conditions

  • Pain

Interventions

  • YZJ-4729Drug

    Loading dose + demand dose

  • Placebo Comparator: SalineDrug

    Loading dose + demand dose

  • Active Comparator: MorphineDrug

    Loading dose + demand dose

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The sum of pain intensity differences in pain score over 48 hours at restTime frame: 48 hours

Locations

21 sites in 1 country. Site status is shown where the registry gives one.

  • The First Hospital of Jilin University

    Ch’ang-ch’un, China

  • The Third Xiangya Hospital of Central South University

    Changsha, China

  • Chengdu Second People's Hospital

    Chengdu, China

  • Sichuan Provincial People's Hospital

    Chengdu, China

  • The Third People's Hospital of Chengdu

    Chengdu, China

  • Dalian University Affiliated Zhongshan Hospital

    Dalian, China

  • Dongguan People's Hospital

    Dongguan, China

  • The First Affiliated Hospital of Zhejiang University School of Medicine

    Hangzhou, China

  • The Second People's Hospital of Hefei

    Hefei, China

  • Jinhua Central Hospital

    Jinhua, China

  • Mianyang Central Hospital

    Mianyang, China

  • The First Affiliated Hospital of Nanchang University

    Nanchang, China

  • Zhongda Hospital Southeast University

    Nanjing, China

  • Ningbo Medical Center Lihuili Hospital

    Ningbo, China

  • The First Affiliated Hospital of Ningbo University

    Ningbo, China

  • The Second Affiliated Hospital of Fujian Medical University

    Quanzhou, China

  • Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

    Shanghai, China

  • Shanghai First People's Hospital

    Shanghai, China

  • The Third Hospital of Hebei Medical University

    Shijiazhuang, China

  • Suzhou University Affiliated Second Hospital

    Suzhou, China

  • Henan Provincial People's Hospital

    Zhengzhou, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.